Atossa Stock Based Compensation from 2010 to 2026

Stocks . USA . 
Stock . Atossa Genetics
ATOS Stock  USD 5.34  0.01  0.19%   
Atossa Genetics Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2026. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2011-06-30
Previous Quarter
796 K
Current Value
784 K
Quarterly Volatility
857 K
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Other Operating Expenses of 33.4 M, Research Development of 17 M or Total Operating Expenses of 33.4 M, as well as many indicators such as Price To Sales Ratio of 116.7 K, Dividend Yield of 0.0 or PTB Ratio of 27.24. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
  
Build AI portfolio with Atossa Stock
Check out the analysis of Atossa Genetics Correlation against competitors.
For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.
The evolution of Stock Based Compensation for Atossa Genetics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Atossa Genetics compares to historical norms and industry peers.

Latest Atossa Genetics' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Atossa Genetics over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Atossa Genetics' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atossa Genetics' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
Compare to OthersAll Fundamentals
   Stock Based Compensation   
       Timeline  

Atossa Stock Based Compensation Regression Statistics

Arithmetic Mean2,568,942
Geometric Mean1,266,837
Coefficient Of Variation97.87
Mean Deviation1,881,926
Median2,292,000
Standard Deviation2,514,277
Sample Variance6.3T
Range8.8M
R-Value0.58
Mean Square Error4.4T
R-Squared0.34
Significance0.01
Slope290,554
Total Sum of Squares101.1T

Atossa Stock Based Compensation History

20262.8 M
20252.6 M
20242.3 M
20234.6 M
20226.8 M
20215.3 M
20203 M

Other Fundumenentals of Atossa Genetics

Stock Based Compensation To Revenue

Atossa Genetics Stock Based Compensation component correlations

Total Assets
Total Stockholder Equity
Net Debt
Retained Earnings
Total Liab
Total Current Assets
Short Term Debt
Common Stock
Accounts Payable
Net Receivables
Short Term Investments
Intangible Assets
Property Plant Equipment
Net Tangible Assets
Capital Surpluse
Current Deferred Revenue
Net Invested Capital
Net Working Capital
Capital Stock
Total Assets
1.0-0.99-0.820.381.0-0.240.940.76-0.28-0.34-0.4-0.490.950.920.440.990.990.94
Total Stockholder Equity
1.0-0.99-0.810.321.0-0.240.930.74-0.27-0.32-0.39-0.480.950.910.420.990.990.93
Net Debt
-0.99-0.990.78-0.38-0.990.24-0.88-0.780.180.320.410.48-0.91-0.87-0.44-0.99-0.99-0.91
Retained Earnings
-0.82-0.810.78-0.48-0.820.33-0.92-0.540.570.470.530.59-0.89-0.96-0.63-0.78-0.77-0.9
Total Liab
0.380.32-0.38-0.480.39-0.160.40.56-0.07-0.28-0.28-0.260.310.420.380.320.310.42
Total Current Assets
1.01.0-0.99-0.820.39-0.230.930.76-0.27-0.32-0.42-0.50.950.920.450.990.990.94
Short Term Debt
-0.24-0.240.240.33-0.16-0.23-0.23-0.230.040.66-0.130.05-0.23-0.3-0.39-0.21-0.21-0.23
Common Stock
0.940.93-0.88-0.920.40.93-0.230.6-0.57-0.31-0.44-0.530.990.980.440.90.90.97
Accounts Payable
0.760.74-0.78-0.540.560.76-0.230.60.19-0.29-0.36-0.290.580.610.490.750.740.63
Net Receivables
-0.28-0.270.180.57-0.07-0.270.04-0.570.190.030.150.21-0.54-0.53-0.11-0.23-0.22-0.51
Short Term Investments
-0.34-0.320.320.47-0.28-0.320.66-0.31-0.290.03-0.220.01-0.3-0.41-0.59-0.28-0.28-0.29
Intangible Assets
-0.4-0.390.410.53-0.28-0.42-0.13-0.44-0.360.15-0.220.65-0.41-0.5-0.48-0.4-0.4-0.42
Property Plant Equipment
-0.49-0.480.480.59-0.26-0.50.05-0.53-0.290.210.010.65-0.51-0.56-0.08-0.49-0.49-0.52
Net Tangible Assets
0.950.95-0.91-0.890.310.95-0.230.990.58-0.54-0.3-0.41-0.510.970.420.930.930.97
Capital Surpluse
0.920.91-0.87-0.960.420.92-0.30.980.61-0.53-0.41-0.5-0.560.970.570.880.870.94
Current Deferred Revenue
0.440.42-0.44-0.630.380.45-0.390.440.49-0.11-0.59-0.48-0.080.420.570.40.40.44
Net Invested Capital
0.990.99-0.99-0.780.320.99-0.210.90.75-0.23-0.28-0.4-0.490.930.880.41.00.93
Net Working Capital
0.990.99-0.99-0.770.310.99-0.210.90.74-0.22-0.28-0.4-0.490.930.870.41.00.93
Capital Stock
0.940.93-0.91-0.90.420.94-0.230.970.63-0.51-0.29-0.42-0.520.970.940.440.930.93
Click cells to compare fundamentals

About Atossa Genetics Financial Statements

Atossa Genetics shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation2.6 M2.8 M
Stock Based Compensation To Revenue 430.09  451.59 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Atossa Stock Analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY